2h96
From Proteopedia
|
Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-terminal Kinase Inhibitors
Contents |
Overview
C-Jun NH2 terminal kinases (JNKs) are important cell signaling enzymes., JNK1 plays a central role in linking obesity and insulin resistance. JNK2, and JNK3 may be involved in inflammatory and neurological disorders, respectively. Small-molecule JNK inhibitors could be valuable tools to, study the therapeutic benefits of inhibiting these enzymes and as leads, for potential drugs targeting JNKs. In this report, we disclose a series, of potent and highly selective JNK inhibitors with good pharmacokinetic, profiles.
Disease
Known diseases associated with this structure: Diabetes mellitus, noninsulin-dependent OMIM:[604641]
About this Structure
2H96 is a Protein complex structure of sequences from Homo sapiens with SO4, 893 and GOL as ligands. Active as Mitogen-activated protein kinase, with EC number 2.7.11.24 Full crystallographic information is available from OCA.
Reference
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors., Zhao H, Serby MD, Xin Z, Szczepankiewicz BG, Liu M, Kosogof C, Liu B, Nelson LT, Johnson EF, Wang S, Pederson T, Gum RJ, Clampit JE, Haasch DL, Abad-Zapatero C, Fry EH, Rondinone C, Trevillyan JM, Sham HL, Liu G, J Med Chem. 2006 Jul 27;49(15):4455-8. PMID:16854050
Page seeded by OCA on Mon Nov 12 22:28:37 2007
